Quirk, Shannon K <br/><br/>
Immune-mediated adverse events of anticytotoxic T lymphocyte-associated antigen 4 antibody therapy in metastatic melanoma.  [electronic resource] 

 -  Translational research : the journal of laboratory and clinical medicine  Nov 2015 
 - 412-24 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review 
<br/><br/><label>ISSN: </label>1878-1810 
<br/><br/><label>Standard No.: </label>10.1016/j.trsl.2015.06.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>CTLA-4 Antigen--immunology<br/>Clinical Trials, Phase III as Topic<br/>Drug Therapy, Combination<br/>Humans<br/>Ipilimumab<br/>Melanoma--drug therapy<br/>Neoplasm Metastasis